Bifogade filer
PDF
Kurs & Likviditet
Kalender
| 2025-01-30 | Bokslutskommuniké 2024 |
| 2024-10-24 | Kvartalsrapport 2024-Q3 |
| 2024-07-17 | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | Ordinarie utdelning VITR 1.00 SEK |
| 2024-04-25 | Årsstämma 2024 |
| 2024-04-18 | Kvartalsrapport 2024-Q1 |
| 2024-02-02 | Bokslutskommuniké 2023 |
| 2023-10-27 | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | Ordinarie utdelning VITR 0.85 SEK |
| 2023-04-27 | Årsstämma 2023 |
| 2023-04-21 | Kvartalsrapport 2023-Q1 |
| 2023-02-02 | Bokslutskommuniké 2022 |
| 2022-10-27 | Kvartalsrapport 2022-Q3 |
| 2022-07-15 | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | Ordinarie utdelning VITR 0.80 SEK |
| 2022-04-27 | Årsstämma 2022 |
| 2022-04-22 | Kvartalsrapport 2022-Q1 |
| 2022-02-16 | Bokslutskommuniké 2021 |
| 2021-10-29 | Kvartalsrapport 2021-Q3 |
| 2021-10-20 | Extra Bolagsstämma 2021 |
| 2021-07-15 | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | Ordinarie utdelning VITR 0.80 SEK |
| 2021-04-28 | Årsstämma 2021 |
| 2021-04-22 | Kvartalsrapport 2021-Q1 |
| 2021-02-10 | Bokslutskommuniké 2020 |
| 2020-11-06 | Kvartalsrapport 2020-Q3 |
| 2020-07-13 | Kvartalsrapport 2020-Q2 |
| 2020-06-16 | Ordinarie utdelning VITR 0.00 SEK |
| 2020-06-15 | Årsstämma 2020 |
| 2020-04-23 | Kvartalsrapport 2020-Q1 |
| 2020-02-06 | Bokslutskommuniké 2019 |
| 2019-11-06 | Kvartalsrapport 2019-Q3 |
| 2019-07-12 | Kvartalsrapport 2019-Q2 |
| 2019-05-03 | Ordinarie utdelning VITR 0.85 SEK |
| 2019-05-02 | Årsstämma 2019 |
| 2019-04-23 | Kvartalsrapport 2019-Q1 |
| 2019-02-08 | Bokslutskommuniké 2018 |
| 2018-11-06 | Kvartalsrapport 2018-Q3 |
| 2018-07-13 | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | Split VITR 1:5 |
| 2018-04-27 | Ordinarie utdelning VITR 3.70 SEK |
| 2018-04-26 | Årsstämma 2018 |
| 2018-04-24 | Kvartalsrapport 2018-Q1 |
| 2018-02-08 | Bokslutskommuniké 2017 |
| 2017-11-02 | Kvartalsrapport 2017-Q3 |
| 2017-07-14 | Kvartalsrapport 2017-Q2 |
| 2017-04-28 | Ordinarie utdelning VITR 2.60 SEK |
| 2017-04-27 | Årsstämma 2017 |
| 2017-04-25 | Kvartalsrapport 2017-Q1 |
| 2017-02-09 | Bokslutskommuniké 2016 |
| 2016-11-03 | Kvartalsrapport 2016-Q3 |
| 2016-09-20 | Kapitalmarknadsdag 2016 |
| 2016-07-15 | Kvartalsrapport 2016-Q2 |
| 2016-04-29 | Ordinarie utdelning VITR 2.40 SEK |
| 2016-04-28 | Årsstämma 2016 |
| 2016-04-26 | Kvartalsrapport 2016-Q1 |
| 2016-02-05 | Bokslutskommuniké 2015 |
| 2015-11-05 | Kvartalsrapport 2015-Q3 |
| 2015-07-14 | Kvartalsrapport 2015-Q2 |
| 2015-05-06 | Ordinarie utdelning VITR 1.50 SEK |
| 2015-05-05 | Årsstämma 2015 |
| 2015-04-28 | Kvartalsrapport 2015-Q1 |
| 2015-02-06 | Bokslutskommuniké 2014 |
| 2014-11-06 | Kvartalsrapport 2014-Q3 |
| 2014-11-06 | Analytiker möte 2014 |
| 2014-11-06 | Kapitalmarknadsdag 2014 |
| 2014-07-11 | Kvartalsrapport 2014-Q2 |
| 2014-05-06 | Ordinarie utdelning VITR 1.00 SEK |
| 2014-05-05 | Årsstämma 2014 |
| 2014-04-23 | Kvartalsrapport 2014-Q1 |
| 2014-02-06 | Bokslutskommuniké 2013 |
| 2013-11-11 | Kapitalmarknadsdag 2013 |
| 2013-11-07 | Kvartalsrapport 2013-Q3 |
| 2013-11-07 | Analytiker möte 2013 |
| 2013-07-12 | Kvartalsrapport 2013-Q2 |
| 2013-04-30 | Ordinarie utdelning VITR 0.60 SEK |
| 2013-04-29 | Årsstämma 2013 |
| 2013-04-19 | Kvartalsrapport 2013-Q1 |
| 2013-03-13 | 15-7 2013 |
| 2013-02-07 | Bokslutskommuniké 2012 |
| 2012-11-01 | Analytiker möte 2012 |
| 2012-11-01 | Kvartalsrapport 2012-Q3 |
| 2012-09-24 | Extra Bolagsstämma 2012 |
| 2012-07-13 | Kvartalsrapport 2012-Q2 |
| 2012-04-20 | Ordinarie utdelning VITR 0.60 SEK |
| 2012-04-19 | Kvartalsrapport 2012-Q1 |
| 2012-04-19 | Årsstämma 2012 |
| 2012-02-07 | Bokslutskommuniké 2011 |
| 2011-10-27 | Kvartalsrapport 2011-Q3 |
| 2011-07-14 | Kvartalsrapport 2011-Q2 |
| 2011-04-28 | Ordinarie utdelning VITR 0.60 SEK |
| 2011-04-27 | Kvartalsrapport 2011-Q1 |
| 2011-04-27 | Årsstämma 2011 |
| 2011-02-09 | Bokslutskommuniké 2010 |
| 2010-11-02 | Kvartalsrapport 2010-Q3 |
| 2010-07-15 | Kvartalsrapport 2010-Q2 |
| 2010-04-27 | Kvartalsrapport 2010-Q1 |
| 2010-04-27 | Ordinarie utdelning VITR 0.50 SEK |
| 2010-04-26 | Årsstämma 2010 |
| 2010-02-05 | Bokslutskommuniké 2009 |
| 2009-11-03 | Kvartalsrapport 2009-Q3 |
| 2009-07-15 | Kvartalsrapport 2009-Q2 |
| 2009-04-28 | Ordinarie utdelning VITR 0.40 SEK |
| 2009-04-27 | Kvartalsrapport 2009-Q1 |
| 2009-04-27 | Årsstämma 1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Bronwyn Brophy has an impressive track record as a leader of global Life science and Medtech businesses. The Board of directors find Bronwyn Brophy to be an exceptional candidate to effectuate Vitrolife's strategy to reach the company's full potential and thereby create increased shareholder value.
Bronwyn Brophy is Irish and has extensive experience of leading positions in Global Life Science and Medtech companies such as Thermo Fisher Scientific, Medtronic and Johnson & Johnson. The last years within Thermo Fischer Bronwyn Brophy was heading the Immunodiagnostics Division globally and before that served as President of the EMEA region.
Bronwyn Brophy will join the company at the latest on 1 August 2023.
As notified 12 September 2022, Thomas Axelsson will leave his position as CEO. This is expected to occur 31 March 2023. At that time Jón Sigurdsson, today Chairman of the board, will assume the position as interim CEO until Bronwyn Brophy starts her appointment. Consequently, the board of directors has appointed the current board member Henrik Blomquist as chairman of the board until the annual general meeting 27 April 2023.
Jón Sigurdsson, chairman of the board, says: "I am very pleased that we have been able to assign Bronwyn Brophy as CEO. She has an extensive experience of developing businesses and has a wide international experience which is important for Vitrolife. Again, I would like to thank Thomas Axelsson for an excellent job done for Vitrolife and for our great cooperation."
Bronwyn Brophy comments the appointment: "I am very honored to the appointment as new CEO of Vitrolife. I believe the company has a very exciting future with great growth potential with strong distributors and global partners".
Thomas Axelsson, CEO, phone: +46 31 721 80 01
Patrik Tolf, CFO, phone: +46 31 766 90 21
This information is information that Vitrolife AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 8.15 am CET on February 1, 2023.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.